2016
DOI: 10.21037/cco.2016.03.23
|View full text |Cite
|
Sign up to set email alerts
|

Nasopharyngeal carcinoma—some closing remarks

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“… 2 NPC, as a disease sensitive to chemotherapy and radiation, is usually treated with intensity‐modulated radiation combined with cisplatin. 3 Unfortunately, most patients are resistant to radiotherapy, leading to tumor recurrence or distant metastasis, which ultimately leads to treatment failure. 4 In recent years, at the cellular and molecular level, it has become a research hotspot to explore and conquer cancer to design targeted therapy for tumor growth inhibition by corresponding therapeutic drugs for cancer locus.…”
Section: Introductionmentioning
confidence: 99%
“… 2 NPC, as a disease sensitive to chemotherapy and radiation, is usually treated with intensity‐modulated radiation combined with cisplatin. 3 Unfortunately, most patients are resistant to radiotherapy, leading to tumor recurrence or distant metastasis, which ultimately leads to treatment failure. 4 In recent years, at the cellular and molecular level, it has become a research hotspot to explore and conquer cancer to design targeted therapy for tumor growth inhibition by corresponding therapeutic drugs for cancer locus.…”
Section: Introductionmentioning
confidence: 99%